Evidence map›Paper›PMID 41231900›Full record

ArticlePloS one2025

Analysis of drug-resistant tuberculosis transmission dynamics in China using fractional stochastic model.

Shaoping Jiang, Hongyan Wang, Yudie Hu

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Socioeconomic Interventions for WHO's End TB Strategy Targets: Insights from SIR Modelling in Kazakhstan.International journal of environmental research and public health · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shaoping JiangSchool of Mathematics and Computer Science, Yunnan Minzu University, Kunming, Yunnan, China.ORCID https://orcid.org/0000-0003-2620-336X
Hongyan WangSchool of Mathematics and Computer Science, Yunnan Minzu University, Kunming, Yunnan, China.ORCID https://orcid.org/0009-0004-2570-0756
Yudie HuSchool of Mathematics and Computer Science, Yunnan Minzu University, Kunming, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the dynamics of the drug-resistant tuberculosis model through a fractional stochastic modeling framework. The model employs fractional-order derivatives to capture the memory effects in disease transmission, while Brownian motion is introduced to represent the random disturbances, thereby providing a more realistic description of the disease dynamics. First, a fractional deterministic model based on the Atangana-Baleanu-Caputo derivative was developed, and its optimal parameter values were obtained from the actual data from the case of drug-resistant tuberculosis in China. Second, the existence and uniqueness of the solution of the fractional stochastic model were proved, and its numerical solution was explored. Furthermore, the impacts of different interventions strategies on the control of drug-resistant tuberculosis in China were compared. The results demonstrate that the combined interventions exhibit superior efficacy compared to any single intervention. Numerical simulations of deterministic and fractional stochastic models verify the effects of memory and random effects on drug-resistant tuberculosis. It was found that as the noise level increases, the degree of random perturbation in the model solution also increases, and higher noise levels may lead to the early disappearance of drug-resistant tuberculosis.

Indexed as

Models, BiologicalTuberculosis, Multidrug-ResistantAntitubercular AgentsChinaComputer SimulationHumansStochastic ProcessesAntitubercular Agents

Identifiers

PMID41231900
PMCPMC12614579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.